A drug some researchers claimed to be incredibly promising in treating COVID-19 is, according to their more in-depth research, potentially promising, with the final results much more lukewarm than they were first described to be.
Anticorps monoclonaux | Un traitement suscite espoir et dissension lapresse.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lapresse.ca Daily Mail and Mail on Sunday newspapers.
MONTREAL Quebec doctors will receive a recommendation early this week from a provincial drug evaluation committee on whether they should prescribe the medication colchicine to treat non-hospitalized COVID-19 patients. The update comes after a tumultuous week that started with a prominent Montreal Heart Institute (MHI) researcher making bold claims in a press release about the effectiveness of the medication and ended with pushback after many scientists were eventually able to scrutinize the study’s data themselves. “We anticipate making our interim position public at the beginning of the week, Tuesday being very likely,” National Institute for Excellence in Health and Social Services (INESSS)spokesperson Olivia Jacques told CTV in an email.